Biotech

All Articles

Enanta's RSV antiviral crushes virus-like lots in challenge study

.Enanta Pharmaceuticals has actually linked its respiratory syncytial virus (RSV) antiviral to consi...

Biogen canisters SAGE-324 cooperation after vital shake stop working

.Biogen has actually carried out the final rites to its own partnership along with Sage Therapeutics...

AbbVie Parkinson's medication from $8.7 B Cerevel buyout credit ratings

.On the same time that some Parkinson's illness drugs are actually being actually cast doubt on, Abb...

Arch closes $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund from Bain Capital Life Sciences, Arc Project Partners is actually...

Orion to utilize Aitia's 'electronic identical twins' to locate brand new cancer cells drugs

.Finnish biotech Orion has spied prospective in Aitia's "electronic identical twin" technology to cr...

Windtree's shock med brings up blood pressure in newest stage 2 gain

.While Windtree Therapies has struggled to expand the monetary origins required to survive, a period...

2 cancer cells biotechs combine, producing global impact

.OncoC4 is taking AcroImmune-- as well as its own internal professional production capabilities-- un...

Amgen documents initial stage 3 gain for $400M dermatitis medicine

.Amgen has shared (PDF) the initial period 3 records on its $400 million eczema drug, linking the an...

Biogen, UCB document phase 3 lupus win after neglecting earlier trial

.Biogen as well as UCB's depend improving right into stage 3 astride an unsuccessful study wants to ...

Aptadir hopes brand-new RNA preventions can easily turn around challenging cancers cells

.Italian biotech Aptadir Rehabs has actually released with the commitment that its own pipeline of p...